UNDERWRITING
Under the terms and conditions set forth in the underwriting agreement, dated the date of this prospectus supplement, Morgan
Stanley & Co. LLC, as underwriter, has agreed to purchase, and we have agreed to sell to the underwriter, 1,400,000 shares of the Series A Preferred Stock.
Under the terms and conditions set forth in the underwriting agreement, the underwriter has committed, subject to the terms and conditions set
forth therein, to take and pay for all of the Series A Preferred Stock if any is taken. The underwriter reserves the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part.
The underwriter initially proposes to offer the Series A Preferred Stock directly to the public at the price to public set forth on the cover
page hereof and may offer the Series A Preferred Stock to certain securities dealers at such price less a concession not in excess of $0.50 per share of the Series A Preferred Stock. The underwriter may allow, and such dealers may reallow to certain
brokers and dealers, a concession not in excess of $0.45 per share of the Series A Preferred Stock. After the initial offering of the Series A Preferred Stock, the offering price and other selling terms may from time to time be varied by the
underwriter.
We have agreed to indemnify the underwriter against certain liabilities, including liabilities under the Securities Act of
1933.
We estimate that our total expenses for this offering will be approximately $640,000, excluding underwriting discounts and
commissions.
The Series A Preferred Stock will constitute a new class of securities with no established trading market. We intend to
apply to list the Series A Preferred Stock on the New York Stock Exchange. If approved for listing, trading of the Series A Preferred Stock on the New York Stock Exchange is expected to commence within 30 days after the Series A Preferred Stock
is first issued. The underwriter has advised us that they intend to make a market in the Series A Preferred Stock prior to the commencement of trading on the New York Stock Exchange, but they are not obligated to do so and may discontinue such
market-making activities at any time without notice. If such a market develops, the Series A Preferred Stock could trade at prices that may be higher or lower than its liquidation value or purchase price, depending on many factors, including
prevailing dividend rates, the market for similar preferred securities and our business, results of operations, financial condition or prospects. We cannot give any assurance as to the maintenance of the trading market for, or the liquidity of, the
Series A Preferred Stock.
During a period of 30 days from the date of the underwriting agreement, we will not, without the prior written
consent of the underwriter, directly or indirectly, sell, offer to sell, grant any option for the sale of, or otherwise dispose of, any share of Preferred Stock that is substantially similar to the Series A Preferred Stock (other than the Series A
Preferred Stock) or any security convertible into or exchangeable into or exercisable for Preferred Stock.
To facilitate the offering of
the Series A Preferred Stock, the underwriter may engage in transactions that stabilize, maintain or otherwise affect the price of the Series A Preferred Stock. Specifically, they may over-allot in connection with the offering, creating a short
position in the Series A Preferred Stock for its own account. In addition, to cover over-allotments or to stabilize the price of the Series A Preferred Stock, the underwriter may bid for, and purchase, the Series A Preferred Stock in the open
market. Finally, the underwriter may reclaim selling concessions allowed to dealers for distributing the Series A Preferred Stock in the offering, if they repurchase previously distributed Series A Preferred Stock in transactions to cover short
positions established by them, in stabilization transactions or otherwise. Any of these activities may stabilize or maintain the market price of the Series A Preferred Stock above independent market levels. The underwriter is not required to engage
in these activities and may end any of these activities at any time.
S-16